HBIO
NASD Harvard Bioscience, Inc.$0.0000 ↓ -8.1300 (-100.00%) Trading Down from the previous close of $8.1300
- YTD change
- N/A
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+2.76 (+51.40%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $87.5000
- HBIO is down 100% since the beginning of the year
- HBIO is down 100% over the past 12 months
- HBIO is down 100% over the past 1 month
- 1% of all HBIO investors are betting against HBIO
HBIO reads poor: the 12-month move is +1739.8%.
- Previous minute
- N/A
- Last hour
- N/A
- Last 5 days
- N/A
- vs 8-day SMA
- N/A
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
